Bahena Culhuac E, Bello M
ACS Omega. 2024; 9(18):20066-20085.
PMID: 38737068
PMC: 11080030.
DOI: 10.1021/acsomega.3c10523.
Kubatka P, Koklesova L, Mazurakova A, Brockmueller A, Busselberg D, Kello M
Cancer Metastasis Rev. 2023; 43(1):87-113.
PMID: 37789138
PMC: 11016017.
DOI: 10.1007/s10555-023-10134-x.
Zhang Y, Huang Y, Li Z, Wu H, Zou B, Xu Y
Cancers (Basel). 2023; 15(14).
PMID: 37509245
PMC: 10377328.
DOI: 10.3390/cancers15143585.
Hung S, Li Y, Chen X, Chu K, Zhao Y, Liu Y
Front Pharmacol. 2022; 13:906746.
PMID: 35860020
PMC: 9289441.
DOI: 10.3389/fphar.2022.906746.
Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M
Antioxidants (Basel). 2022; 11(6).
PMID: 35740092
PMC: 9227079.
DOI: 10.3390/antiox11061195.
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.
Fakhri S, Moradi S, Yarmohammadi A, Narimani F, Wallace C, Bishayee A
Front Oncol. 2022; 12:834072.
PMID: 35299751
PMC: 8921560.
DOI: 10.3389/fonc.2022.834072.
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck.
Shin D, Nannapaneni S, Patel M, Shi Q, Liu Y, Chen Z
Clin Cancer Res. 2020; 26(22):5860-5868.
PMID: 32943457
PMC: 8016407.
DOI: 10.1158/1078-0432.CCR-20-2276.
ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma.
Chen J, Chen L, Lu T, Xie Y, Li C, Jia Z
Int J Clin Exp Pathol. 2020; 12(9):3222-3234.
PMID: 31934166
PMC: 6949832.
Flavonoids in Cancer and Apoptosis.
Abotaleb M, Samuel S, Varghese E, Varghese S, Kubatka P, Liskova A
Cancers (Basel). 2019; 11(1).
PMID: 30597838
PMC: 6357032.
DOI: 10.3390/cancers11010028.
Pharmacology of natural radioprotectors.
Mun G, Kim S, Choi E, Kim C, Lee Y
Arch Pharm Res. 2018; 41(11):1033-1050.
PMID: 30361949
PMC: 6224001.
DOI: 10.1007/s12272-018-1083-6.
Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications.
Abedin M, Umapathi S, Mahendrakar H, Laemthong T, Coleman H, Muchangi D
J Nanobiotechnology. 2018; 16(1):80.
PMID: 30316298
PMC: 6186064.
DOI: 10.1186/s12951-018-0405-7.
Phyto-polyphenols as potential inhibitors of breast cancer metastasis.
Avtanski D, Poretsky L
Mol Med. 2018; 24(1):29.
PMID: 30134816
PMC: 6016885.
DOI: 10.1186/s10020-018-0032-7.
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.
Naponelli V, Ramazzina I, Lenzi C, Bettuzzi S, Rizzi F
Antioxidants (Basel). 2017; 6(2).
PMID: 28379200
PMC: 5488006.
DOI: 10.3390/antiox6020026.
Preparation and characterization of (-)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on Human breast cancer MCF-7 cells.
Zeng L, Yan J, Luo L, Ma M, Zhu H
Sci Rep. 2017; 7:45521.
PMID: 28349962
PMC: 5368574.
DOI: 10.1038/srep45521.
Green tea polyphenols induce cell death in breast cancer MCF-7 cells through induction of cell cycle arrest and mitochondrial-mediated apoptosis.
Liu S, Ou S, Huang H
J Zhejiang Univ Sci B. 2017; 18(2):89-98.
PMID: 28124838
PMC: 5296226.
DOI: 10.1631/jzus.B1600022.
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Granja A, Pinheiro M, Reis S
Nutrients. 2016; 8(5).
PMID: 27213442
PMC: 4882719.
DOI: 10.3390/nu8050307.
Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal Diseases.
Varela-Lopez A, Bullon P, Giampieri F, Quiles J
Antioxidants (Basel). 2016; 4(3):447-81.
PMID: 26783837
PMC: 4665427.
DOI: 10.3390/antiox4030447.
Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.
Wang Y, Huang Y, Anreddy N, Zhang G, Zhang Y, Xie M
Oncotarget. 2015; 7(5):5877-91.
PMID: 26716507
PMC: 4868728.
DOI: 10.18632/oncotarget.6711.
Chemoprevention of Breast Cancer by Dietary Polyphenols.
Mocanu M, Nagy P, Szollosi J
Molecules. 2015; 20(12):22578-620.
PMID: 26694341
PMC: 6332464.
DOI: 10.3390/molecules201219864.
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers.
Petric R, Braicu C, Raduly L, Zanoaga O, Dragos N, Monroig P
Onco Targets Ther. 2015; 8:2053-66.
PMID: 26273208
PMC: 4532173.
DOI: 10.2147/OTT.S83597.
